Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
GlobeNewswire
· Pathway leverages immunobridging approach via serum virus neutralizing antibody (sVNA) titers enabled by prior successful..